Unilever (UL) is Said to Edge Out Nestle for GlaxoSmithKline's (GSK) India Unit, Said to Offer About $3B for 70% - Bloomberg
Tweet Send to a Friend
Unilever (NYSE: UL) is Said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE